In the group of severe COVID-19 patients who were recruited in this study, genetic admixture estimations using HLA class I and HLA class II MHC genes revealed 60% of Amerindian component, 30% of European component, and <10% of African genes (Zuñiga J, et al., unpublished data). This evidence concerns the gene HLA-C and COVID-19.